home All News open_in_new Full Article

PharmaMar se hunde un 9% en bolsa tras perder 3,95 millones de euros hasta marzo

Los ingresos recurrentes se elevaron un 19%. Más información: PharmaMar dispara su beneficio hasta los 26,1 millones de euros en 2024


today 3 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1202234862
Add Watch Country

arrow_drop_down